HEALTH SENSE INFANTS IBUPROFEN ORAL SUSPENSION- ibuprofen suspension
Ibuprofen 50 mg (NSAID)*
*nonsteroidal anti-inflammatory drug
Pain reliever/fever reducer
- reduces fever
- relieves minor aches and pains due to the common cold, flu, sore throat, headaches and toothaches
Allergy alert: Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
- facial swelling
- asthma (wheezing)
- skin reddening
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding.
The chance is higher if the child:
- has had stomach ulcers or bleeding problems
- takes a blood thinning (anticoagulant) or steroid drug
- takes other drugs containing an NSAID [aspirin, ibuprofen, naproxen, or others]
- takes more or for a longer time than directed
Sore throat warning: Severe or persistent sore throat or sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. Consult doctor promptly. Do not use more than 2 days or administer to children under 3 years of age unless directed by doctor.
- if the child has ever had an allergic reaction to any other pain reliever/fever reducer
- right before or after heart surgery
- problems or serious side effects from taking pain relievers or fever reducers
- stomach problems that last or come back, such as heartburn, upset stomach, or stomach pain
- bleeding problems
- not been drinking fluids
- lost a lot of fluid due to vomiting or diarrhea
- high blood pressure
- heart or kidney disease
- taken a diuretic
- taking any other drug containing an NSAID (prescription or nonprescription)
- taking a blood thinning (anticoagulant) or steroid drug
- under a doctor’s care for any serious condition
- taking any other drug
- give with food or milk if stomach upset occurs
- long term continuous use may increase the risk of heart attack or stroke
- the child feels faint, vomits blood, or has bloody or black stools. These are signs of stomach bleeding.
- stomach pain or upset gets worse or lasts
- the child does not get any relief within first day (24 hours) of treatment
- fever or pain gets worse or lasts more than 3 days
- redness or swelling is present in the painful area
- any new symptoms appear
In case of overdose, get medical help or contact a Poison Control Center right away.
- this product does not contain directions or complete warnings for adult use
- do not give more than directed
- do not give longer than 10 days, unless directed by a doctor (see Warnings)
- shake well before using
- find the right dose on chart below. If possible, use weight to dose; otherwise use age.
- measure with dosing device provided. Do not use with any other device.
- dispense liquid slowly into the child’s mouth, toward the inner cheek
- if needed, repeat dose every 6-8 hours
- do not use more than 4 times a day
|Weight (lb)||Age (mos)||Dose (mL)|
|under 6 mos||ask a doctor|
|12-17 lbs||6-11 mos||1.25 mL|
|18-23 lbs||12-23 mos||1.875 mL|
- do not use if printed neckband is broken or missing
- store at 20-25°C (68-77°F)
- see bottom of box for lot number and expiration date
artificial flavor, butylparaben, citric acid, FD&C red #40, glycerin, hypromellose, polysorbate 80, propylene glycol, purified water, sodium benzoate, sorbitol, sucrose, xanthan gum
Compare to active ingredient of Motrin® Infants’ Drops
For Ages 6 mos.-23 mos.
Infants’ Ibuprofen Oral Suspension
50 mg per 1.25 mL
Pain Reliever/Fever Reducer (NSAID)
Lasts up to 8 hours
Use Only With Enclosed Syringe
| HEALTH SENSE INFANTS IBUPROFEN
ORAL SUSPENSION |
|Labeler — Dolgencorp Inc (068331990)|
Revised: 05/2009 Dolgencorp Inc
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.